{"id":785968,"date":"2023-09-25T16:20:19","date_gmt":"2023-09-25T20:20:19","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\/"},"modified":"2023-09-25T16:20:19","modified_gmt":"2023-09-25T20:20:19","slug":"gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\/","title":{"rendered":"Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023"},"content":{"rendered":"
\n

BETHESDA, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (the \u201cCompany\u201d), a biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that the Company\u2019s Chief Executive Officer, Matthias Alder, will participate in a fireside chat and host one-on-one meetings at Cantor Fitzgerald Global Healthcare Conference taking place in New York, NY, September 26-28, 2023.<\/p>\n

\n Presentation Details<\/strong>
\n
Date: September 28, 2023
Time: 12:40 p.m. ET
Format: Fireside Chat<\/p>\n

Please contact your Cantor Fitzgerald representative for more information.<\/p>\n

A webcast of the presentation can be accessed through the Events section of the Company\u2019s website at https:\/\/www.gaintherapeutics.com\/investors-media\/overview.html. An archived replay of the webcast will be available on the Company\u2019s website following the conference.<\/p>\n

\n About Gain Therapeutics, Inc.<\/strong>\n <\/p>\n

Gain Therapeutics, Inc. is a biotechnology company leading the discovery and development of next generation allosteric therapies. Gain\u2019s lead drug candidate GT-02287, in development for the treatment of GBA1 Parkinson\u2019s disease, has been approved for clinical testing in Australia.<\/p>\n

Leveraging AI-supported structural biology, proprietary algorithms and supercomputer-powered physics-based models, the company\u2019s SEE-Tx\u00ae<\/sup> discovery platform can identify novel allosteric binding sites on disease-implicated proteins, pinpointing pockets that cannot be found or drugged with current technologies. Gain\u2019s unique approach enables the discovery of novel, allosteric small molecule modulators that can restore or disrupt protein function. Deploying its highly advanced platform, Gain is accelerating drug discovery and unlocking novel disease-modifying treatments for untreatable or difficult-to-treat disorders including neurodegenerative diseases, rare genetic disorders and oncology. For more information, please visit\u00a0GainTherapeutics.com<\/u><\/a> and follow us on\u00a0LinkedIn<\/u><\/a>.<\/p>\n

\n Investor & Media Contact:<\/strong>\n <\/p>\n

Susan Sharpe
Linnden Communications
(919) 602-2330
susan@linndencom.com<\/u><\/a><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

BETHESDA, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (the \u201cCompany\u201d), a biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that the Company\u2019s Chief Executive Officer, Matthias Alder, will participate in a fireside chat and host one-on-one meetings at Cantor Fitzgerald Global Healthcare Conference taking place in New York, NY, September 26-28, 2023. Presentation Details Date: September 28, 2023Time: 12:40 p.m. ETFormat: Fireside Chat Please contact your Cantor Fitzgerald representative for more information. A webcast of the presentation can be accessed through the Events section of the Company\u2019s website at https:\/\/www.gaintherapeutics.com\/investors-media\/overview.html. An archived replay of the webcast will be available on the Company\u2019s website following the … <\/p>\n

Continue reading “Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-785968","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nGain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BETHESDA, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (the \u201cCompany\u201d), a biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that the Company\u2019s Chief Executive Officer, Matthias Alder, will participate in a fireside chat and host one-on-one meetings at Cantor Fitzgerald Global Healthcare Conference taking place in New York, NY, September 26-28, 2023. Presentation Details Date: September 28, 2023Time: 12:40 p.m. ETFormat: Fireside Chat Please contact your Cantor Fitzgerald representative for more information. A webcast of the presentation can be accessed through the Events section of the Company\u2019s website at https:\/\/www.gaintherapeutics.com\/investors-media\/overview.html. An archived replay of the webcast will be available on the Company\u2019s website following the … Continue reading "Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-25T20:20:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyODEwNyM1ODMxNTA5IzIyMDkwMzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023\",\"datePublished\":\"2023-09-25T20:20:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\\\/\"},\"wordCount\":288,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyODEwNyM1ODMxNTA5IzIyMDkwMzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\\\/\",\"name\":\"Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyODEwNyM1ODMxNTA5IzIyMDkwMzA=\",\"datePublished\":\"2023-09-25T20:20:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyODEwNyM1ODMxNTA5IzIyMDkwMzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyODEwNyM1ODMxNTA5IzIyMDkwMzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\/","og_locale":"en_US","og_type":"article","og_title":"Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023 - Market Newsdesk","og_description":"BETHESDA, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (the \u201cCompany\u201d), a biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that the Company\u2019s Chief Executive Officer, Matthias Alder, will participate in a fireside chat and host one-on-one meetings at Cantor Fitzgerald Global Healthcare Conference taking place in New York, NY, September 26-28, 2023. Presentation Details Date: September 28, 2023Time: 12:40 p.m. ETFormat: Fireside Chat Please contact your Cantor Fitzgerald representative for more information. A webcast of the presentation can be accessed through the Events section of the Company\u2019s website at https:\/\/www.gaintherapeutics.com\/investors-media\/overview.html. An archived replay of the webcast will be available on the Company\u2019s website following the … Continue reading \"Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-25T20:20:19+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyODEwNyM1ODMxNTA5IzIyMDkwMzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023","datePublished":"2023-09-25T20:20:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\/"},"wordCount":288,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyODEwNyM1ODMxNTA5IzIyMDkwMzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\/","name":"Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyODEwNyM1ODMxNTA5IzIyMDkwMzA=","datePublished":"2023-09-25T20:20:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyODEwNyM1ODMxNTA5IzIyMDkwMzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyODEwNyM1ODMxNTA5IzIyMDkwMzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gain-therapeutics-to-participate-at-cantor-fitzgerald-global-healthcare-conference-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/785968","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=785968"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/785968\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=785968"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=785968"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=785968"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}